Achieve Life Sciences Inc
Permanently closed
Advertisement
520 Pike St Ste 2250
Seattle, WA 98101
OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance.
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement